Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed.

CAS：78-28-4
中文别名：
英文别名：3-Carbamoyloxy-3-methyl-pentan;Emylcamate;Striatan;Restetal;Striatran;3-Pentanol, 3-methyl-, carbamate;Statran;1-ethyl-1-methylpropyl carbamate;Carbamidsaeure-<1-methyl-1-aethyl-propylester>;Emylcamat;Stratran;Nuncital;Emilcamato;Psicoplegil;
分子式：C7H15NO2
分子量：145.199
精确质量：145.11
Psa：52.32
Logp：2.3607

UNII：KCJ747D3R4

密度：0.959g/cm3
沸点：233.3ºC at 760 mmHg
闪点：92.7ºC
折射率：1.438